(Q47849943)

English

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

author name string

S Oparil

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

R Guthrie

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

A J Lewin

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

T Marbury

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

K Reilly

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

J Triscari

6

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

J A Witcher

7

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

publication date

1 May 1998

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

Clinical Therapeutics

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

20

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

398-409

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response relationships following oral administration of DuP 753 to normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

24-Hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-related efficacy of irbesartan for hypertension: an integrated analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980051-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(98)80051-9

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

release_ezunjbhjmjcuvj4nwj4qgvfnai

1 reference

https://api.fatcat.wiki/v0/release/ezunjbhjmjcuvj4nwj4qgvfnai

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/9663357

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47849943&oldid=2172815910"